These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 17523580)

  • 21. Survey of alcohol, tobacco, and cannabis use in the French army.
    Marimoutou C; Queyriaux B; Michel R; Verret C; Haus-Cheymol R; Mayet A; Deparis X; Boutin JP
    J Addict Dis; 2010 Jan; 29(1):98-106. PubMed ID: 20390703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Increasing trends in screening for addictives behaviors among general practitioners in France].
    Beck F; Guignard R; Obradovic I; Gautier A; Karila L
    Rev Epidemiol Sante Publique; 2011 Oct; 59(5):285-94. PubMed ID: 21940125
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Erectile Dysfunction among People Who Use Ketamine and Poly-Drugs.
    Suppiah B; Vicknasingam B; Singh D; Narayanan S
    J Psychoactive Drugs; 2016; 48(2):86-92. PubMed ID: 27014841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anomalous bodily-self experiences among recreational ketamine users.
    Wilkins LK; Girard TA; Cheyne JA
    Cogn Neuropsychiatry; 2012; 17(5):415-30. PubMed ID: 22414229
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantifying the psychological effects of ketamine: from euphoria to the k-Hole.
    Stirling J; McCoy L
    Subst Use Misuse; 2010 Dec; 45(14):2428-43. PubMed ID: 21039109
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Ketamine--a trendy doping agent in the mass media?].
    Oye I
    Tidsskr Nor Laegeforen; 2000 May; 120(12):1464-6. PubMed ID: 10851946
    [No Abstract]   [Full Text] [Related]  

  • 27. The prevalence and natural history of urinary symptoms among recreational ketamine users.
    Winstock AR; Mitcheson L; Gillatt DA; Cottrell AM
    BJU Int; 2012 Dec; 110(11):1762-6. PubMed ID: 22416998
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study.
    de Sola Llopis S; Miguelez-Pan M; Peña-Casanova J; Poudevida S; Farré M; Pacifici R; Böhm P; Abanades S; Verdejo García A; Langohr K; Zuccaro P; de la Torre R
    J Psychopharmacol; 2008 Jul; 22(5):498-510. PubMed ID: 18208910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Ketamine-induced urinary symptoms].
    Reinhardt S; Fode M
    Ugeskr Laeger; 2014 Feb; 176(3):243-4. PubMed ID: 24629753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Addictive behaviors and healthcare renunciation for economic reasons in a French population-based sample.
    Baggio S; Dupuis M; Richard JB; Beck F
    Int J Drug Policy; 2017 Nov; 49():1-7. PubMed ID: 28818639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].
    Guillem E; Pelissolo A; Vorspan F; Bouchez-Arbabzadeh S; Lépine JP
    Encephale; 2009 Jun; 35(3):226-33. PubMed ID: 19540408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Crystal methamphetamine smoking among regular ecstasy users in Australia: increases in use and associations with harm.
    Kinner SA; Degenhardt L
    Drug Alcohol Rev; 2008 May; 27(3):292-300. PubMed ID: 18368611
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ketamine is associated with lower urinary tract signs and symptoms.
    Pal R; Balt S; Erowid E; Erowid F; Baggott MJ; Mendelson J; Galloway GP
    Drug Alcohol Depend; 2013 Sep; 132(1-2):189-94. PubMed ID: 23474358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beyond the K-hole: a 3-year longitudinal investigation of the cognitive and subjective effects of ketamine in recreational users who have substantially reduced their use of the drug.
    Morgan CJ; Monaghan L; Curran HV
    Addiction; 2004 Nov; 99(11):1450-61. PubMed ID: 15500598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Commentary on Morgan et al. (2010): ketamine abuse: first medical evidence of harms we should confront.
    De La Torre R
    Addiction; 2010 Jan; 105(1):134-5. PubMed ID: 20078466
    [No Abstract]   [Full Text] [Related]  

  • 36. [Bladder pain and urinary tract symptoms as a consequence of ketamine abuse].
    Reinhardt S; Fode M
    Ugeskr Laeger; 2014 Feb; 176(3):240-2. PubMed ID: 24629752
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of drug use in French seamen.
    Fort E; Massardier-Pilonchéry A; Facy F; Bergeret A
    Addict Behav; 2012 Mar; 37(3):335-8. PubMed ID: 22130516
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug use patterns and drug-related disorders of cocaine users in a sample of the general population in Germany.
    Kraus L; Augustin R; Kunz-Ebrecht S; Orth B
    Eur Addict Res; 2007; 13(2):116-25. PubMed ID: 17356284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dimethyltryptamine (DMT): prevalence, user characteristics and abuse liability in a large global sample.
    Winstock AR; Kaar S; Borschmann R
    J Psychopharmacol; 2014 Jan; 28(1):49-54. PubMed ID: 24284475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug injection practices among high-risk youths: the first shot of ketamine.
    Lankenau SE; Clatts MC
    J Urban Health; 2004 Jun; 81(2):232-48. PubMed ID: 15136657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.